Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Timing conversions into stablecoins can protect gains during drawdowns. This piece outlines indicators and decision points for choosing pivots.
10,194 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Analysts lift Intel targets on AI-driven demand, sending shares higher. The move underscores optimism about data cent...
Nvidia has stumbled from its record highs in 2026, but a dip can offer opportunity—if you know how to evaluate the od...
Stocks wobble as a fresh batch of analyst notes lands on top names like Albemarle, American Express and CME Group. He...
A fresh market thesis points to a higher Oracle share price by 2027, anchored in AI-driven cloud growth and a swellin...
A Thursday rally put Oklo in the spotlight after a strategic supply agreement. This piece breaks down what happened, ...